• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Antimicrobial technology

July 1, 2003

An antimicrobial technology from Engelhard Corp. has been granted registration by the U.S. Environmental Protection Agency (EPA) for use against tuberculosis (TB) and other animal pathogens in veterinary applications.

An antimicrobial technology from Engelhard Corp. has been granted registration by the U.S. Environmental Protection Agency (EPA) for use against tuberculosis (TB) and other animal pathogens in veterinary applications.Engelhards Aseptrol technology can be tailored to release chlorine dioxide, a potent germ killer, at precise rates and in controlled concentrations when it comes in contact with water or moisture in the air.Chlorine dioxide has been used in industrial applications for many years, but until development of Engelhards patented, controlled-release technology, the powerful biocide could not be incorporated into a stable, easy-to-use form, such as dry powder.The new registration authorizes Aseptrol for use against TB, canine parvovirus, mouse hepatitis virus (MHV), sialodacryoadenitis virus (SDAV), murine parainfluenza virus type 1 (Sendai), mouse parvovirus type 1 (MPV-1), and minute virus of mice (MVM) in animal rearing and confinement facilities, such as kennels and cages. The technology is at the heart of Quip Laboratories MB-10 tablets, which are designed for disinfecting animal confinement areas and hard surfaces, and for eliminating odors from animal waste. Engelhard also is conducting efficacy tests to secure EPA registration for use of Aseptrol against other animal pathogens, including the Norwalk virus, foot and mouth disease and Newcastle virus. Available in sachet and tablet form, Aseptrol is being used in a widening range of consumer and industrial purification and deodorization applications. Last year the technology received EPA registration for use in purifying drinking water.

For fastest response call or visit the Web site at www.engelhard.com.

Related Content:

Products
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening
Study reveals Zymox Otic Plus is beneficial and effective
Study reveals Zymox Otic Plus is beneficial and effective

Advertisement

Latest News

Partners for Health Pets and VHMA collaboration publish white paper

Vetstoria releases its Fill Rate platform

What's new with the "Dentistry Lane" across the veterinary profession?

Meet the BlackDVM Network

View More Latest News
Advertisement